CYP1B1 Antibodies

Santa Cruz Biotechnology delivers a wide array of CYP1B1 monoclonal antibodies for research focused on understanding this important enzyme. CYP1B1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP1B1 is a member of the cytochrome P450 superfamily and plays a crucial role in the metabolism of various endogenous and exogenous compounds, including hormones and environmental toxins. CYP1B1's function is particularly significant in cancer research, as it contributes to the bioactivation of procarcinogens and has been associated with various malignancies. Understanding CYP1B1 expression and regulation can provide insights into its potential as a therapeutic target and biomarker in cancer treatment. Researchers worldwide rely on CYP1B1 monoclonal antibodies to advance their studies in cellular metabolism and drug development. The specificity and reliability of CYP1B1 monoclonal antibodies enable precise detection and analysis of this enzyme across multiple experimental platforms. Santa Cruz Biotechnology's CYP1B1 monoclonal antibodies contribute to advancing scientific knowledge by supporting researchers in their quest to understand enzyme function and its implications in disease progression.